schihei/covid19-age-stratified-ifr
1
0
Fork 0
Code Issues Pull Requests Actions Packages Projects Releases Wiki Activity

update README

Browse Source
This commit is contained in:
Marc Bevand
2020-10-07 22:24:49 -07:00
parent 82cbf26066
commit e549e9b473
1 changed files with 4 additions and 4 deletions
Download Patch File Download Diff File Expand all files Collapse all files
README.md
+4 -4
View File
@@ -321,10 +321,6 @@ IFR: Japan at 1.274-1.605% (excluding Levin et al.)
The country with the youngest population is expected to have the lowest overall The country with the youngest population is expected to have the lowest overall
IFR: Uganda at 0.074-0.147%. IFR: Uganda at 0.074-0.147%.
The **IFR of COVID-19 is one order of magnitude (10×) higher than the seasonal flu**
for all regions. For example, in the US the average flu IFR is 0.078%, compared to
0.669-1.169% for COVID-19.
The **overall IFR varies dramatically by more than 10-fold** between countries with a young The **overall IFR varies dramatically by more than 10-fold** between countries with a young
population and those with an old population. population and those with an old population.
@@ -347,6 +343,10 @@ predicted an overall IFR of 0.669% in the United States, which is very close to
[overall US CDC estimate of 0.65%](https://web.archive.org/web/20200712055258/https://www.cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios.html) [overall US CDC estimate of 0.65%](https://web.archive.org/web/20200712055258/https://www.cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios.html)
published in July 2020. published in July 2020.
The **IFR of COVID-19 is one order of magnitude (10×) higher than the seasonal flu**
for all regions. For example, in the US the average flu IFR is 0.078%, compared to
0.669-1.169% for COVID-19.
# Calculating the age-stratified IFR of COVID-19 from the Spanish ENE-COVID study # Calculating the age-stratified IFR of COVID-19 from the Spanish ENE-COVID study
The largest serological prevalence survey of COVID-19 was conducted by Spain The largest serological prevalence survey of COVID-19 was conducted by Spain